newsfilter
← Latest News
PR Newswire·

Petauri Expands Global Medical Communications Capabilities With Acquisition of Emotive

  • Petauri announced the acquisition of global medical communications agency Emotive on November 10, 2026.
  • The deal strengthens Petauri Advance, expanding its global scale & adding scientific, strategic, & creative expertise.
  • Emotive, founded in 2023, specializes in neuroscience, immunology, oncology, & rare diseases.
  • Emotive joins Petauri Advance alongside agencies DRIVE, PROPEL, MOMENTUM, BluPrint Oncology, Verascity Science, & Cogency.
  • Chris Edmonds, Emotive Founder & CEO, will serve as Executive Advisor while preserving Emotive's client partnerships.
  • Petauri now employs over 600 global professionals across market access & scientific communications.
  • The acquisition follows Petauri's 2023 founding by CEO Dan Renick & Oak Hill Capital, which has invested over $250 million.
  • Oak Hill Capital's OHCP VI fund supports the platform's strategy to launch & combine best-in-class life sciences companies.
  • Petauri operates six business units: Petauri Advance, Petauri Advisors, Petauri Evidence, Petauri Kinect, Petauri MAx, & Artia Solutions.
  • The combined entity aims to improve patient outcomes by demonstrating the clinical & economic value of innovative medicines to global stakeholders.
Company
Petauri
Keywords
Petauri